Into Care Medical Technology Completed D Round Financing with Oriza FOFs Joint Investment

Recently, Into Care Medical Technology (Into Care), a global leader in electric staplers, announced its completion of a D round financing of hundreds of million.

Chipsea Tech Shenzhen Successfully Went Public: Oriza FOFs’ STAR Board Adds Another Member

On September 28, 2020, the Oriza FOFs’ portfolio has a new company listed on the Science and Technology Innovation Board: Chipsea Technology (Shenzhen) Co., Ltd.

Oriza FOFs Congratulates Sansure Biotech and Two Others Going Public

On August 28, 2020, 3 companies in the FOFs portfolio managed by Oriza FOFs were simultaneously listed in China and the United States. Among them, there are

The First Batch of Companies under the Second Board Registration System Listed: Oriza FOFs Have Three Investees Listed

On August 24, 2020, the Second Board ushered in a historic moment when the first batch of 18 companies listed under the registration system went public. Among the first batch

Oriza FOFs IPO Harvest: iRay Technokogy, CanSino Biologics etc. Successfully Passed the Meeting

In the past month, 8 companies in the FOFs portfolio managed by Oriza FOFs have successfully passed the meeting: 6 on the STAR Board, 1 on Second Board and 1 on SME Board. Among them, Yangling Metron New Materials is expected to become the first batch of centralized listing enterprises after the reform of the STAR Board registration system.

Oriza FOFs Congratulates Qi An Xin Technology, Sansure Biotech and Genetron Health Successfully Passed the Meeting

Recently, in the FOFs investment portfolio managed by Oriza FOFs, 3 companies have successfully passed the meeting to go public. Among them, there are 2 companies STAR Board listed: Qi An Xin Technology, Sansure Biotech. Beijing Genetron Gene Technology Co., Ltd. ("GTH") is listed on NASDAQ in the United States.